» Articles » PMID: 11448232

ElogD(oct): a Tool for Lipophilicity Determination in Drug Discovery. 2. Basic and Neutral Compounds

Overview
Journal J Med Chem
Specialty Chemistry
Date 2001 Jul 13
PMID 11448232
Citations 45
Authors
Affiliations
Soon will be listed here.
Abstract

We present an RP-HPLC method for the determination of the octanol-water distribution coefficients at pH 7.4, as log values, for neutral and basic drugs, which combines ease of operation with high accuracy. The method is shown to work for a training set of 90 molecules comprised largely of drugs, and it was also applied to a test set of 10 proprietary compounds. This work expands the applicability of the method presented in our earlier report, for the determination of logP(oct) for neutral compounds (J. Med. Chem. 2000, 43, 2922-2928), and it offers the same general features but widens the scope. Generally, the method (i) is compound sparing (< or =1 mL of a 50-100 microg/mL solution needed), (ii) is insensitive to concentration and phase ratio effects observed in some shake-flask determinations, (iii) is amenable to rapid determinations (< or = 20 min on average), (iv) is insensitive to impurities, (v) possesses a wide lipophilicity range (>7 log units), and (vi) offers a good accuracy, (vii) an excellent reproducibility, (viii) and an excellent potential for automation. To the best of our knowledge, a similar performance, on a set of noncongeneric drugs, has not been previously reported. We refer to the value generated via this method as ElogD(oct).

Citing Articles

Application of drug-induced growth rate inhibition and intracellular drug exposures for comprehensive evaluation of cellular drug sensitivity.

Maji D, Wolke M, Khaja S, Savaryn J, Kalvass J, Jenkins G Sci Rep. 2025; 15(1):5064.

PMID: 39934176 PMC: 11814085. DOI: 10.1038/s41598-025-86919-7.


Development and evaluation of [C]DPA-813 and [F]DPA-814: novel TSPO PET tracers insensitive to human single nucleotide polymorphism rs6971.

Beaino W, Jm Kooijman E, Werry E, Vellinga R, Van den Hoek J, Sohler G Eur J Nucl Med Mol Imaging. 2025; .

PMID: 39907797 DOI: 10.1007/s00259-025-07109-1.


Molecular properties, including chameleonicity, as essential tools for designing the next generation of oral beyond rule of five drugs.

Jimenez D, Vallaro M, Vitagliano L, Lopez L, Apprato G, Ermondi G ADMET DMPK. 2024; 12(5):721-736.

PMID: 39524220 PMC: 11542721. DOI: 10.5599/admet.2334.


Chromatographic Determination of Permeability-Relevant Lipophilicity Facilitates Rapid Analysis of Macrocyclic Peptide Scaffolds.

Koch G, Engstrom A, Taechalertpaisarn J, Faris J, Ono S, Naylor M J Med Chem. 2024; 67(21):19612-19622.

PMID: 39453819 PMC: 11571107. DOI: 10.1021/acs.jmedchem.4c01956.


Toxicokinetics of a developmental toxicity test in zebrafish embryos and larvae: Relationship with drug exposure in humans and other mammals.

Nawaji T, Mizoguchi N, Adachi R, Teraoka H Curr Res Toxicol. 2024; 7:100187.

PMID: 39104612 PMC: 11298605. DOI: 10.1016/j.crtox.2024.100187.